CRH Medical (CRH Medical) FCF Margin % : 30.42% (As of Dec. 2020)

View and export this data going back to 2008. Start your Free Trial

What is CRH Medical FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CRH Medical's Free Cash Flow for the three months ended in Dec. 2020 was $11.2 Mil. CRH Medical's Revenue for the three months ended in Dec. 2020 was $36.8 Mil. Therefore, CRH Medical's FCF Margin % for the quarter that ended in Dec. 2020 was 30.42%.

As of today, CRH Medical's current FCF Yield % is 13.42%.

The historical rank and industry rank for CRH Medical's FCF Margin % or its related term are showing as below:

CRHM' s FCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 33.86
Current: 33.86

During the past 13 years, the highest FCF Margin % of CRH Medical was 33.86%. The lowest was 0.00%. And the median was 0.00%.

CRHM's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -7.29 vs CRHM: 33.86

CRH Medical FCF Margin % Historical Data

The historical data trend for CRH Medical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CRH Medical FCF Margin % Chart

CRH Medical Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

FCF Margin %

Get a 7-Day Free Trial

41.87

37.50

36.33

37.34

33.86

CRH Medical Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
FCF Margin %	Get a 7-Day Free Trial															40.57	30.58	67.53	25.72	30.42

Competitive Comparison of CRH Medical's FCF Margin %

For the Medical Instruments & Supplies subindustry, CRH Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CRH Medical's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CRH Medical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CRH Medical's FCF Margin % falls into.

CRH Medical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CRH Medical's FCF Margin for the fiscal year that ended in Dec. 2020 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2020 )	/	Revenue (A: Dec. 2020 )
	=	35.952	/	106.172
	=	33.86 %

CRH Medical's FCF Margin for the quarter that ended in Dec. 2020 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2020 )	/	Revenue (Q: Dec. 2020 )
	=	11.189	/	36.783
	=	30.42 %

CRH Medical FCF Margin % Related Terms

Thank you for viewing the detailed overview of CRH Medical's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CRH Medical (CRH Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CRH Medical Corp (AMEX:CRHM) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

999 Canada Place, Suite 578, World Trade Center, Vancouver, BC, CAN, V6C 3E1

Website

https://www.crhsystem.com

CRH Medical Corp is a healthcare products and services company. The company, through its subsidiaries, provides anesthesiology services to gastroenterologists in the United States. It also specializes in the treatment of hemorrhoids utilizing its treatment protocol and patented proprietary technology. The company's product, the CRH O'Regan System, is a single-use, disposable, hemorrhoid treatment. It distributes the CRH O'Regan System, treatment protocols, operational and marketing services directly to gastroenterologists. Geographically, the company operates in the United States and Canada, of which key revenue is derived from the United States.

Executives

Richard Bear	officer: Chief Financial Officer	9062 NE 37TH PLACE, BELLEVUE WA 98004
Ian Webb	director	7385 LABURNUM ST VANCOUVER A1 V6P 5N2
James Kreger	officer: President	2580 ACORN AVE NE ATLANTA GA 30305
Tushar M Ramani	director, officer: Chief Executive Officer	118 TALAVERA PLACE PALM BEACH GARDENS FL 33418
Brian T Griffin	director
Todd Patrick	director	9029 NE 36TH STREET, BELLEVUE WA 98004
David Allan Johnson	director	7464 NORTH SHORE ROAD NORFOLK VA 23505
Anthony F Holler	director	8855 NORTHBROOK CT BURNABY A1
Edward Wright	officer: Chief Financial Officer	2992 WEST 31ST AVE VANCOUVER A1 V6L 2A4